Gene: NUP35
Official Full Name: nucleoporin 35provided by HGNC
Gene Summary: This gene encodes a member of the nucleoporin family. The encoded protein contains two membrane binding regions, is localized to the nuclear rim, and is part of the nuclear pore complex. All molecules entering or leaving the nucleus either diffuse through or are actively transported by the nuclear pore complex. Alternative splicing results in multiple transcript variants. Pseudogenes of this gene have been defined on chromosomes 7 and 10. [provided by RefSeq, Dec 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26681 | NUP35 Knockout cell line (HeLa) | Human | NUP35 | 1:3~1:6 | Negative | Online Inquiry |
KO26682 | NUP35 Knockout cell line (HCT 116) | Human | NUP35 | 1:2~1:4 | Negative | Online Inquiry |
KO26683 | NUP35 Knockout cell line (HEK293) | Human | NUP35 | 1:3~1:6 | Negative | Online Inquiry |
NUP35 Gene Knockout Cell Lines are genetically modified cellular models designed to lack the NUP35 gene, which encodes a component of the nuclear pore complex (NPC). This specialized cell line allows researchers to study the functional implications of NUP35 in cellular processes such as nucleocytoplasmic transport, gene expression regulation, and cellular responses to stress. By precisely eliminating this gene, researchers can investigate the role of NUP35 in disease models and basic cellular biology, providing insights into how alterations in nuclear transport may influence cellular physiology and pathology.
The primary function of NUP35 involves its participation in the assembly and maintenance of the nuclear pore complex, essential for the regulation of molecular trafficking between the nucleus and cytoplasm. The knockout of this gene leads to discernible phenotypic changes, helping elucidate the consequences of its absence. Such insights can be critical when probing the mechanisms underlying various diseases, particularly those involving nuclear transport dysregulation, such as cancer and neurodegenerative disorders.
Scientifically, these cell lines are invaluable tools in both research and clinical applications. They enable the evaluation of therapeutic targets related to nuclear transport and facilitate the validation of drug compounds designed to modify nucleocytoplasmic transport pathways. By utilizing NUP35 Gene Knockout Cell Lines, researchers are better equipped to develop novel therapeutic strategies and biomarkers.
Unique advantages of these cell lines include their specificity, reproducibility, and the availability of high-quality genetic modification techniques applied during their development. Compared to traditional cell line models that may carry heterogeneous backgrounds, these knockout lines provide consistent experimental conditions that yield more reliable data.
For researchers and clinicians looking to advance their studies in cellular transport mechanisms, the NUP35 Gene Knockout Cell Lines offer an unparalleled resource that enhances the understanding of nucleocytoplasmic dynamics in health and disease. Our company specializes in providing state-of-the-art genetic models and maintains a commitment to facilitating groundbreaking research by offering products that meet the highest standards of quality and precision in the field of biotechnology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.